November 21, 2017 / 10:09 AM / a month ago

BRIEF-Sangui Biotech International Q1 operating loss of $62,283

Nov 21 (Reuters) - SANGUI BIOTECH INTERNATIONAL INC :

* SALES OF USD 16,636 IN THE FIRST QUARTER; COSTS AND LOSS IS FURTHER REDUCED

* ‍Q1 OPERATING LOSS DECREASED USD 7,610 TO USD 62,283 FROM PRIOR YEAR​

* Q1/2018 ‍REVENUES FROM ROYALTY INCOME AND PRODUCT SALES OF USD 16,636​

* ‍EXPECTS REVENUES FOR ENTIRE CALENDAR YEAR 2017 AS WELL AS CORRESPONDING ROYALTIES OVER SAME PERIOD LAST YEAR​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below